THE NEW YORKER 
The artificial heart poses a unique challenge:only those confronting imminent death are willing to use today’s models, and yet nearly 660,000 Americans die of heart disease annually—a pandemic-level death toll. An increasing number of us live with diseased hearts and suffer the consequences. To realize their full potential, artificial hearts must get good enough that people actually want to use them; they must be preferable not to death but to a failing heart, the way hip replacements are preferable to failing hips. Meanwhile, until they achieve wider adoption, they will remain a niche product—and so be unavailable to many people who need them. Link to full article here.